Fig. 2From: Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort studyFlowchart in the secondary analysis of PPI use and complications of COVID-19 diseaseBack to article page